Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs
about
Understanding natural herpes simplex virus immunity to inform next-generation vaccine designHerpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections.Future prospects for new vaccines against sexually transmitted infections.Nuclear Magnetic Resonance (NMR) Study for the Detection and Quantitation of Cholesterol in HSV529 Therapeutic Vaccine Candidate.
P2860
Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Immunogenicity, protective eff ...... HSV529 in mice and guinea pigs
@ast
Immunogenicity, protective eff ...... HSV529 in mice and guinea pigs
@en
type
label
Immunogenicity, protective eff ...... HSV529 in mice and guinea pigs
@ast
Immunogenicity, protective eff ...... HSV529 in mice and guinea pigs
@en
prefLabel
Immunogenicity, protective eff ...... HSV529 in mice and guinea pigs
@ast
Immunogenicity, protective eff ...... HSV529 in mice and guinea pigs
@en
P2093
P2860
P1433
P1476
Immunogenicity, protective eff ...... HSV529 in mice and guinea pigs
@en
P2093
Aymeric de Montfort
Catherine Caillet
Fabrine Pradezynski
Marie-Clotilde Bernard
Patricia Londono-Hayes
Robert Ryall
Véronique Barban
P2860
P304
P356
10.1371/JOURNAL.PONE.0121518
P407
P577
2015-04-02T00:00:00Z